Paul Andrea 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Paul Andrea
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-01+290,500→ 290,500 totalExercise: $28.82Exp: 2032-07-31→ Common Stock (290,500 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer.